What is CI's health score?

Cigna Group (CI) has a TradeApes health score of 74 out of 100, rated Healthy. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is CI's estimated fair value?

Based on our 5-year discounted cash flow model, Cigna Group's estimated fair value is $374.85 per share, representing a 29.5% upside from the current price. This is a model estimate, not a price target or investment recommendation.

Is CI undervalued or overvalued?

Our model currently rates CI as Undervalued. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

Crunching the numbers for CI... Refresh in a moment for the full analysis.

Cigna Group (CI)

Financials Undervalued medium healthy

$289.48

Updated: 2026-06-06

TradeApes Score

Financial Strength

75 Strong

Operating Trend

58 Mixed

Relative Value

85 Strong

Capital Allocation

80 Strong

Risk

70 Healthy

Est. Fair Value $374.85

DCF Upside +29.5%

Sector Rank #7 of 6245

Key Findings

+ Historically cheap — EV/EBITDA in bottom 25% of its 5-year range

Unlock Full Report →

− Weak liquidity — current assets below current liabilities

Unlock Full Report →

2 free score cards remaining

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.